欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5724/001
药品名称Serkep 25 Mikrogramm/125 Mikrogramm pro Sprühstoß Druckgasinhalation, Suspension
活性成分
    • fluticasone propionate 125.0 µg/dose
    • salmeterol 25.0 µg/dose
剂型Pressurised inhalation, solution
上市许可持有人Mylan Germany GmbH Luetticher Strasse 5 D-53842 Troisdorf Germany
参考成员国 - 产品名称Germany (DE)
Serkep 25 Mikrogramm/125 Mikrogramm pro Sprühstoß Druckgasinhalation, Suspension
互认成员国 - 产品名称
    • Denmark (DK)
    • Austria (AT)
    • Ireland (IE)
    • Iceland (IS)
    • Greece (GR)
      SALMETEROL+FLUTICASONE/MYLAN
    • Finland (FI)
    • Italy (IT)
    • Lithuania (LT)
      Serkep 25/125 mikrogramai/dozėje suslėgtoji įkvepiamoji suspensija
    • Norway (NO)
    • Portugal (PT)
    • Latvia (LV)
      Serkep 25/125 mikrogrami/devā aerosols inhalācijām, zem spiediena, suspensija
    • Cyprus (CY)
      Salmeterol + Fluticasone Mylan
    • Czechia (CZ)
      Sirdupla 25 mikrogramů/ 125 mikrogramů/ dávka SUS k INH v tlakovém obalu
    • Estonia (EE)
      Serkep
    • Hungary (HU)
      SERHALYX 25/125 mikrogramm/adag túlnyomásos inhalációs szuszpenzió
    • Croatia (HR)
    • Malta (MT)
    • Slovakia (SK)
许可日期2015/04/28
最近更新日期2024/02/19
药物ATC编码
    • R03AK06 salmeterol and fluticasone
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase